What is Cyanotech?
Cyanotech Corporation is a global leader in microalgae technology, renowned for its production of BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®. These premium, all-natural ingredients are foundational to dietary supplements and health products designed to promote overall well-being. Leveraging patented and proprietary cultivation techniques at its 96-acre facility in Kona, Hawaii, Cyanotech ensures the highest quality and safety standards, with its products recognized as Generally Recognized as Safe (GRAS) for food applications. The company's mission is to harness the power of Hawaiian microalgae to deliver comprehensive health solutions, with its offerings supporting antioxidant activity, skin, eye, and joint health, as well as cardiovascular and immune system functions.
How much funding has Cyanotech raised?
Cyanotech has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Cyanotech?
With the recent major strategic investment, Cyanotech is poised to further solidify its market leadership and potentially expand its product development and distribution channels. The enterprise-level funding suggests a strategic focus on scaling operations, enhancing research into novel microalgae applications, and broadening its reach within the nutraceutical and cosmeceutical industries. This capital infusion is expected to fuel innovation in its core product lines and explore new avenues for growth, reinforcing its commitment to fulfilling the promise of whole health through advanced microalgae science.
See full Cyanotech company page
